This section is dedicated to smartbriefs, short communications or annoucements (e.g PhD defense dates, NM staf, thematic Glem…) that may represent an interest for the Belgian Nuclear Medicine community.
BELNUC ’23 Symposium Registration & Abstract Submission Open Now!
Registration for the BELNUC ’23 symposium and Abstract Submission are open now! Benefit from early-bird registration fee discount now.
BELNUC 2023 Membership renewal available
Membership renewal for 2023 is now available on the myBELNUC platform! Go to myBELNUC and renew today to continue to benefit from your BELNUC membership!
CALL FOR EANM BOARD MEMBERS
In line with § 7.2.3 of the EANM Statutes, the EANM Board hereby gives notice that the following EANM Board positions are open for election: President Elect 2023-2024 – elected by the Delegates’ Assembly Committee Coordinator 2023-2024 – elected by the Delegates’ Assembly Secretary/Treasurer 2023-2024 – elected by the Members´ Assembly Scientific Liaison Officer 2023-2024 – […]
Precision imaging at the speed of tomorrow – Program announced!
Join the official satellite symposium of the BELNUC ’22 Antwerp Symposium presented by GE Healthcare on Friday evening (May 6) from 19:00 at Antwerp Expo, followed by the opportunity to meet your colleagues during the opening reception!
Register for the BELNUC ’22 Antwerp Symposium
There is still time to book your seat for the BELNUC ’22 Antwerp Symposium! More information on www.belnuc22.be
EANM Statement on iodine self-medication
Due to the current situation in Ukraine, many people are wondering whether the prophylactic intake of iodine preparations can be beneficial in the event of a nuclear incident. The answer to this question is definitely NO. The potential harm to the thyroid is by far exceeding any theoretical benefit. Additionally, to date, there is no […]
New BELNUC board installed
The new BELNUC board was installed during the General Assembly of BELNUC on 12/3/2022. Meet the new team!
BELNUC 2022 Membership renewal available
Membership renewal for 2022 is now available on the myBELNUC platform! Go to myBELNUC and renew today to continue to benefit from your BELNUC membership!
General Assembly & Seminar Registration Now Open
Join us for the BELNUC 2022 General Assembly and Seminar on Saturday March 12th 2022 9:00 – 12:30 at the ULB campus Erasme.
BELNUC ’22 Antwerp Symposium Registration and Abstract Submission Open
Registration and abstract submission are now open for the BELNUC ’22 Antwerp symposium! Benefit from early-bird registration fee discounts!
Webinar “NET near to our heart” – 14/12/2021
On 14 December 2021 at 19h00 UZ Leuven organizes the online webinar: “NET near to our heart” (FANC/AFCN registration requested). More information and registration on the event website.
Open call: Board and Tech Board members
Help shape the future of BELNUC and the Belgian nuclear medicine community! Multiple vacancies are available in the BELNUC Board for election during the upcoming General Assembly and the BELNUC Tech Board is also looking to reinforce their team.
European Course on Lymphatic Imagings In the Management of (Lymph)Edemas and Benign Lymphatic Pathologies
European Course on Lymphatic Imagings In the Management of (Lymph)Edemas and Benign Lymphatic Pathologies COURSE 2022 GOES VIRTUAL! Title Type: continuing education Category(s) – Thematic(s): Health – Medical Sciences Organizing faculty(ies) and university(s): Centre for Continuing Education in Health and Life Sciences and Free University of Brussels Language(s) of instruction: English / French Duration of training: […]
Industry partnership opportunities now available for BELNUC ’22 Antwerp Symposium
Reuniting the nuclear medicine community after difficult times, the BELNUC ’22 Antwerp symposium is the prime event to showcase your latest products, services, and developments! Multiple sponsorship opportunities are now available! Contact our office for details: email@example.com!
BELNUC Seminar and Tech Day 13/11/2021 Registration Now Open
Registration for the BELNUC seminar “Education and scientific innovation in Nuclear Medicine” and for the Tech Day ’21 held in conjunction on November 13th 2021 are now open! Both events are free for members but registration is required (deadline 9/11/2021).
Positive results presented of the VISION trial
During the virtual ASCO 2021 meeting, the highly anticipated results of the phase III study with radioligand therapy 177Lu-PSMA-617 in patients with advanced prostate cancer (VISION trial) were presented.
Odisee survey on the use of artificial intelligence
The professional bachelor program in medical imaging and radiotherapy of Odisee wishes, by means of a short survey, to examine to what extent artificial intelligence is already present in the field and how the program should adapt the future curriculum to this. The opinion of the nuclear medicine physician is very important to us. It […]
Open call tech board members
The BELNUC Tech Board is looking for enthusiastic new members to join their team and help shape the future of technologist’s representation within our society. Do you want to contribute to improving the science and practice of nuclear medicine? Send in your application today using the form below!
European Course on Lymphatic Imagings In the Management of (Lymph)Edemas and Benign Lymphatic Pathologies – COURSE 2021 GOES VIRTUAL!
European Course on Lymphatic Imagings In the Management of (Lymph)Edemas and Benign Lymphatic Pathologies COURSE 2021 GOES VIRTUAL! Dear colleagues, Many things have changed since COVID-19 entered our lives, but one stubborn fact has remained the same: large, in-person gatherings are a public health risk. While we are all hoping for a breakthrough […]
2021 General Assembly and Cardiology Seminar – Registration Open!
Registration for the 2021 General Assembly and Cardiology Seminar, taking place on March 06, 2021 is now open.
BELNUC Membership 2021
BELNUC membership renewal 2021 is now possible! Attention: As BELNUC is using a new database, your “old” username and password are not valid anymore. Click here to start your membership renewal Please be aware that all member-accounts of the previous 2 years have been transferred into our new membership-database. Everybody who has been transferred to […]
Survey on the treatment of hypothyroidism
The Belgian Thyroid Club is conducting a short survey (+/- 10 min) on the treatment of hypothyroidism, in collaboration with the European Thyroid Association (ETA).
VIRTUAL ONLY: BELNUC Seminar – Radiopharmaceutical Radiobiology Advances in nuclear medicine : The future is now
Due to the new corona outbreak, the scheduled seminar on 14/11/2020 will be held as a live webinar only. There will be no in-person meeting! If you have previously registered for the seminar, you do not have to do anything and you will receive your login details over the next weeks. Discover the program or […]
How to become BELNUC member?
As we are working on our database infrastructure, the “Become BELNUC member”-button is temporarily out of action. However, we continue to welcome new members! See our Membership Application and Renewal page for more details: www.belnuc.be/belnuc-membership
EANM ’20 Virtual for Technologists
This year, the EANM congress will once again provide a full program dedicated to technologists. The focus will be on topics that are important for current practice in the nuclear medicine field, a sector in which scientific and technological advancements have been great. A wide range of subjects will be covered during the Congress. These […]
FANC/AFCN Patient Release Card
A FANC/AFCN technical decree published on August 3rd 2020 specifies the information that must appear on the discharge card given to a person who has been administered a radioactive product for radiotherapeutic purposes. You can download the FANC/AFCN templates in the “Library” on the BELNUC member section.
European Course on Lymphatic lmagings ln the Management of (Lymph-)Edemas And Benign Lymphatic Pathologies
To be held from the 23rd to the 28th of November 2020, this course offer training-teaching in the different imaging techniques of the lymphatic system (Lymphoscintigraphies, Nuclear Magnetic Resonance lymphangiographies, Lympho-Fluoroscopies and others) used in the management of (lymh)edemas (and other benign lymphatic pathologies), not only theoretical but also and above all practical (diagnoses integrated […]
New ESMO guideline endorses PET/CT for bone imaging
A new European Society for Medical Oncology (ESMO) clinical practice guideline on Bone Health in Cancer has been published in Annals of Oncology, endorsing “FDG-PET-CT imaging as the most accurate way of assessing treatment response of hypermetabolic bone metastasis”.
EANM ’20 VIRTUAL dates announced
EANM’s virtual 2020 annual meeting will be held from October 22nd until October 30th.
EANM ’20 becomes VIRTUAL
EANM president prof. Wim Oyen announced today that even though technically allowed to run as a conference in Vienna, the difficult decision was taken that it is in the best interest of the entire Nuclear Medicine community to hold the EANM ’20 meeting virtual only. Further updates on https://eanm20.eanm.org.
EANM considers it “very likely that we can hold EANM’20 as an onsite congress”
In the first edition of its new weekly Wed@Noon newsletter, EANM announced that “the Austrian government has now approved up to 5,000 people attending events in closed spaces from September. Therefore, it is very likely that we can hold EANM’20 as an onsite congress. And you can rest assured that EANM will take all necessary […]
European Commission’s Joint Research Centre survey on radiopharmaceuticals for therapy
The European Commission’s Joint Research Centre, on request of the Council of the European Union, has launched a study and survey to increase the insight in the current and future use of radiopharmaceuticals for therapy in Europe: https://technopolisgroup.limequery.org/642128?lang=en.
ASCO 2020: 177Lu-PSMA more active than cabazitaxel in first analysis of randomized TheraP trial in mCRPC after docetaxel
Professor Michael Hofman presented the first results at the ASCO 2020 Virtual meeting from the randomized TheraP trial, comparing 177Lu-PSMA-617 with cabazitaxel in men with metastatic castration-resistant prostate cancer (mCRPC) after treatment with docetaxel. 177Lu-PSMA-617 was more effective than cabazitaxel, with fewer adverse events and PSA-PFS favoring 177Lu-PSMA-617.
Antwerp 2021 symposium – The Trailer is now online!
Passing the torch from Liège to Antwerp, BELNUC has the pleasure to announce its 20th bi-annual symposium to be held in the city on the river Scheldt. This cosmopolitan, down to earth city is full of fascinating architecture and historical institutions, complemented by a lively nightlife. Watch the trailer below and save the date on […]
Participate in the IAEA INCAPS COVID-19 survey
Over the past decade, the International Atomic Energy Agency, part of the United Nations family of organizations, has conducted a number of surveys of worldwide cardiac imaging practice. Cardiac imaging laboratories worldwide have been impacted by COVID-19. The INCAPS team believes that it is important to understand the impact that COVID-19 has had on nuclear […]
ASNC Virtual Cardiovascular Molecular Imaging Seminars
The American Society of Nuclear Cardiology (ASNC) has developed a virtual educational program. These webinars are intended as a platform to promote the value of cardiovascular molecular imaging. We expect molecular imaging researchers and trainees to interact and learn from each other, and network virtually with global leaders in cardiovascular molecular imaging. The format is […]
SNMMI Annual Meeting 2020 to be replaced by Virtual Edition
In the wake of the COVID-19 crisis, SNMMI President Dr. Vasken Dilsizian announced yesterday that the SNMMI 2020 Annual Meeting that was scheduled to be held in New Orleans (June 13-16) will be replaced by a Virtual Edition (July 11–14). This truly innovative virtual experience will be free for all SNMMI members, with discounted registration […]
Impact of COVID-19 on nuclear medicine practice
What is the impact of the COVID-19 crisis on nuclear medicine in Europe? Colleagues from Germany and Italy are running online questionnaires to help gather insights in how we are adapting our practice. Contribute your piece of the puzzle!
FANC/AFCN decision personal license
Recognizing current operational challenges, the FANC/AFCN has decided to exempt doctors who use ionising radiation in medicine from the continuous training necessary for the renewal of their license, as far as the year 2020 is concerned. In addition, it has been decided that all physicians using ionising radiation in medicine whose license expires between 13 […]
Recommendations for performing V/Q scans in the context of COVID-19
Substituting ventilation scintigraphy by CT as part of stand-alone perfusion SPECT/CT is not recommended, as this reduces the specificity of the study. Both perfusion and ventilation studies should be performed to rule out pulmonary embolism.
Belgian Society of Radiology guidelines for chest CT imaging during COVID-19
The Belgian Society for Radiology has published guidelines for the appropriate use of chest CT scans during the COVID-19 crisis.
Beware of possible COVID-19 related chest CT abnormalities on hybrid imaging studies
Attenuation or localization CT scans on SPECT/CT or PET/CT studies incorporating the chest should be screened in lung window regardless of their clinical indication. In case abnormalities are identified an experienced radiologist should be consulted in order to ensure appropriate patient referral.
Temporary lifting of ban to perform stand-alone CT on hybrid imaging devices by RIZIV/INAMI
Due to COVID-19, starting from March 14th hybrid imaging devices may be used to perform stand-alone CT studies until further notice according to a RIZIV/INAMI statement published on March 23rd
BELNUC endorses the CNP recommendations for nuclear medicine departments during the COVID-19 crisis
Read more: https://www.belnuc.be/belnuc-covid-19-recommendations
COVID19 – Nuclear Medicine Departments, be prepared!
The Paper of the Month April 2020 is online early and devoted to the COVID-19 crisis. Read it in your BELNUC member section now!
CANCELLED: Meet the Oncology Expert
CANCELLED: Due to travel restrictions this lecture has unfortunately been cancelled and will be rescheduled later this year. Believing is seeing: evolving role of theranostics for imaging and treatment of prostate cancer From 8:00 till 9:00 AM. Breakfast from 7:30 AM Michael HOFMAN, MBBS, FRACP Peter MacCallum Cancer Centre, University of Melbourne, Australia Location: Institut […]
Book announcement “Charles Pecher (1913 – 1941) et le Strontium Radioactif”
The new book “Charles Pecher (1913 – 1941) et le Strontium Radioactif” recounts the discoveries, the life and the tragic end of Charles Pecher, Belgian pioneer in nuclear medicine whose work has long been ignored. The book is now available as an e-book on different platforms. It is written in French, but a 38 page […]
Event Tip: Winter School “Dosimetry Guided Treatment Planning for Radionuclide Therapy”
The dosimetry winter school takes place from March 04 to March 06, 2020 in Bern, Switzerland
SYMPOSIUM BHPA 2020 (including a BELNUC session)
We would like to inform you that BELNUC will present a session at the SYMPOSIUM BHPA 2020 entitled “Personalization of radionuclide therapy, with focus on predictive/effective dosimetry” on Saturday February 8, 2020.
Event tip: 2nd SLN symposium: SLN in Head and Neck Cancer
Please see below an invitation to the 2nd SLN Symposium: 12.30 – Welcome – Lunch 13.00 – SLN symposium The patient’s journey Nuclear medicine: Preparation, Injection & Imaging SLNB Surgery & Pathology / SLN guided Radiotherapy 16.00 – 17.00 Discussion Invitation 2nd symposium – December 13, 2019